undamentalytics Newsletter
Sign in

Astrana Health, Inc. income statement

In fiscal 2025, Astrana Health, Inc. reported revenue of $3.18bn, up 56.4% on the year before, operating income of $78.5m (a 2.5% margin) and net income of $22.5m, or $0.46 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Jan 20112012Jan 20122013Jan 20132014Jan 20142015Mar 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue45810333063565205616877741,1441,3872,0353,1823,844
Cost of revenue——————273361468539596—————
Gross profit1111——8315993148178—————
General and administrative11451121264341496278113154217239
Operating income0−0−2−4−1123588328198104858979100
Interest expense00111001595816335067
Income before tax−0−1−9−5−119508326178788790814060
Income tax000009422856324132311621
Net income−0−1−9−5−21126111438694561432241
Diluted EPS−$0.01−$0.20−$2.70−$1.37−$0.37$0.41$0.90$0.29$0.39$1.01$1.52$0.99$1.29$0.90$0.46$0.82
Diluted shares (average)—3m3m4m5m28m29m38m36m37m45m46m47m48m49m49m
EBITDA0−0−2−4−030541085199116122102117124163

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AMN vs ASTHASTH vs CHEASTH vs AVAHASTH vs OPCH

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Astrana Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Astrana Health, Inc.